[{"AccountsPayableCurrent_0_Q1_USD":74210000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":-7552000.0,"AccruedIncomeTaxesNoncurrent_0_Q1_USD":68118000.0,"AccruedMarketingCostsCurrent_0_Q1_USD":60025000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":8604000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":7284000.0,"CapitalizedContractCostNet_0_Q1_USD":16000000.0,"CapitalizedContractCostNetCurrent_0_Q1_USD":5302000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":1278000.0,"CapitalizedContractCostNetNoncurrent_0_Q1_USD":10672000.0,"CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_1_Q1_USD":-6500000.0,"CommonStockOtherSharesOutstanding_0_Q1_shares":144000.0,"ContractWithCustomerAssetNetNoncurrent_0_Q1_USD":69196000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":38028000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":49042000.0,"DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_1_Q1_USD":36300000.0,"DeferredCostsCurrent_0_Q1_USD":39719000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-8931000.0,"DerivativeNotionalAmount_0_Q1_USD":202300000.0,"SalesCommissionsAndFees_1_Q1_USD":1400000.0,"TreasuryStockValueAcquiredCostMethod_1_Q1_USD":187767000.0,"TreasuryStockShares_0_Q1_shares":20985000.0,"TreasuryStockValue_0_Q1_USD":2788310000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":102792000.0,"OtherAssetsCurrent_0_Q1_USD":128329000.0,"ProvisionForLoanLeaseAndOtherLosses_1_Q1_USD":4229000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":81395000.0,"ProceedsFromIssuanceOfSeniorLongTermDebt_1_Q1_USD":0.0,"ProceedsFromRepaymentsOfOtherDebt_1_Q1_USD":198110000.0,"ContractWithCustomerAssetNetCurrent_0_Q1_USD":18670000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-22206000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":57948000.0,"OtherAssetsMiscellaneousNoncurrent_0_Q1_USD":34717000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":7300000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":71568000.0,"SecuredLongTermDebt_0_Q1_USD":697363000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":81293000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-2410000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-4033000.0,"IncomeTaxesReceivableNoncurrent_0_Q1_USD":14960000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":64881000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_1_Q1_USD":2052000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1_Q1_USD":1101000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_1_Q1_USD":240000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":-13000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_1_Q1_USD":0.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":8604000.0,"PrepaidExpenseOtherNoncurrent_0_Q1_USD":13785000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_1_Q1_USD":9426000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":10210000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":626336000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":2796000.0,"SalesTypeLeaseLeaseReceivable_0_Q1_USD":7700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_1_Q1_pure":0.27,"SharesPaidForTaxWithholdingForShareBasedCompensation_1_Q1_shares":30000.0,"StockIssuedDuringPeriodValueShareBasedCompensationGross_1_Q1_USD":9750000.0,"TreasuryStockAcquiredAverageCostPerShare_1_Q1_USD":250.77,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q1_USD":1101000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1_Q1_USD":-7963000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1_Q1_USD":-89000.0,"OtherAssetsMiscellaneousCurrent_0_Q1_USD":17085000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":42290000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":20970000.0,"LeaseIncome_1_Q1_USD":4200000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":96358000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":33376000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":6813000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":10300000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":14695000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":17676000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":13498000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":15522000.0,"OperatingLeaseLiability_0_Q1_USD":80836000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":15493000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":65343000.0,"OperatingLeasePayments_1_Q1_USD":5015000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":78612000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.035,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":84.21,"TreasuryStockSharesAcquired_1_Q1_shares":751000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-279000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":148384000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":16901000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-49670000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":27871000.0,"NetIncomeLoss_1_Q1_USD":111827000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":49002000.0,"ProfitLoss_1_Q1_USD":111856000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":546158000.0,"LiabilitiesNoncurrent_0_Q1_USD":931949000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":1705646000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":247179000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":7000000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.1,"CommonStockSharesAuthorized_0_Q1_shares":120000000.0,"InterestExpense_1_Q1_USD":7692000.0,"OperatingIncomeLoss_1_Q1_USD":144325000.0,"StockholdersEquity_0_Q1_USD":107674000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":182815000.0,"LiabilitiesCurrent_0_Q1_USD":846241000.0,"Liabilities_0_Q1_USD":1778190000.0,"AccountsReceivableNetCurrent_0_Q1_USD":299983000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":33351000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-55246000.0,"Assets_0_Q1_USD":1886245000.0,"AssetsCurrent_0_Q1_USD":721351000.0,"AssetsNoncurrent_0_Q1_USD":1164894000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":81395000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1886245000.0,"CommonStockSharesIssued_0_Q1_shares":105914000.0,"CommonStockValue_0_Q1_USD":10591000.0,"CostOfRevenue_1_Q1_USD":266746000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":65812000.0,"GrossProfit_1_Q1_USD":359590000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":24917000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":38062000.0,"InventoryNet_0_Q1_USD":211644000.0,"CommonStockSharesOutstanding_0_Q1_shares":84929000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":33310000.0,"ShareBasedCompensation_1_Q1_USD":7284000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.015,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1230485000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":668000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":102763000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":29000.0,"OperatingLeaseExpense_1_Q1_USD":5400000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-9064000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":136773000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":66742000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":7172000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":23204000.0,"IncomeTaxesReceivable_0_Q1_USD":15150000.0,"SellingAndMarketingExpense_1_Q1_USD":116143000.0,"DeferredCosts_0_Q1_USD":98463000.0,"EarningsPerShareDiluted_1_Q1_USD":1.29,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":75100000.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":-1755000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":2853000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":85427000.0,"SharePrice_0_Q1_USD":288.78,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":86705000.0,"CommonStockOtherValueOutstanding_0_Q1_USD":4508000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":38908000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.182,"IncomeTaxesPaid_1_Q1_USD":12020000.0,"IncreaseDecreaseInInventories_1_Q1_USD":14434000.0,"InterestAndOtherIncome_1_Q1_USD":140000.0,"OtherAccruedLiabilitiesNoncurrent_0_Q1_USD":13175000.0,"PrepaidExpenseCurrent_0_Q1_USD":32403000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":108055000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":14123000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":266746000.0,"EarningsPerShareBasic_1_Q1_USD":1.31,"Goodwill_0_Q1_USD":233211000.0,"MinorityInterest_0_Q1_USD":381000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":29000.0,"OtherAssetsNoncurrent_0_Q1_USD":248965000.0,"LinesOfCreditCurrent_0_Q1_USD":486824000.0,"TreasuryStockValueAcquiredParValueMethod_1_Q1_USD":188227000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20200430"}]